About Alphyn Biologics
Alphyn Biologics is a private company based in Annapolis, Maryland. It has reported $9,328,198 raised in four offerings on Form D since February 2020. Its chief executive is Neal Koller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 19, 2023 | May 20, 2024 | $1,185,717of $1.7M target | 17 | $69,748 | EquityRule 506(b) | Form D ↗ |
| Mar 28, 2024 | Apr 15, 2024 | $5,172,484fully sold | 18 | $287K | EquityRule 506(b) | Form D ↗ |
| May 19, 2022 | May 23, 2022 | $2,169,997of $3.4M target | 7 | $309K | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2020 | Feb 6, 2020 | $800,000of $1.5M target | 5 | $160K | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $9,328,198 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alphyn Biologics's Form D filed May 20, 2024.
SP
Steven Pentelnik
Executive officer
JK
Jeffrey Kossak
Director
GP
Gary Pekoe
Executive officer and director
AM
Adel Mikhail
Director
RG
Roger Griggs
Director
NK
Neal Koller
Chief Executive Officer and director
Earlier filings also listed Tony Shipley (director, last listed Apr 2024).